Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage
Authors
Keywords
-
Journal
FASEB JOURNAL
Volume 35, Issue 2, Pages -
Publisher
Wiley
Online
2021-01-22
DOI
10.1096/fj.202002113r
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Land of Controversy: Fibroblast Growth Factor-23 and Uremic Cardiac Hypertrophy
- (2020) Jing-Fu Bao et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation
- (2019) Daniela Egli-Spichtig et al. KIDNEY INTERNATIONAL
- Regulation of fibroblast growth factor 23 ( FGF 23) in health and disease
- (2019) Ludmilla Bär et al. FEBS LETTERS
- Mechanisms of phosphate transport
- (2019) Moshe Levi et al. Nature Reviews Nephrology
- FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
- (2019) Daniel Edmonston et al. Nature Reviews Nephrology
- Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats
- (2018) Yasuto Shikida et al. CALCIFIED TISSUE INTERNATIONAL
- The participation of fibroblast growth factor 23 (FGF23) in the progression of osteoporosis via JAK/STAT pathway
- (2018) Lijun Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease
- (2018) Frank Bienaimé et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury
- (2018) Luis Toro et al. KIDNEY INTERNATIONAL
- Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease
- (2018) Karina Durlacher-Betzer et al. KIDNEY INTERNATIONAL
- Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men
- (2018) Arezoo Daryadel et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Elevated FGF23 Levels in Mice Lacking the Thiazide-Sensitive NaCl cotransporter (NCC)
- (2018) Ganesh Pathare et al. Scientific Reports
- Phosphate-dependent FGF23 secretion is modulated by PiT2/Slc20a2
- (2018) Nina Bon et al. Molecular Metabolism
- FGF23 Actions on Target Tissues—With and Without Klotho
- (2018) Beatrice Richter et al. Frontiers in Endocrinology
- Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies
- (2018) Mary Scott Roberts et al. JOURNAL OF CLINICAL INVESTIGATION
- Renal and extrarenal effects of fibroblast growth factor 23
- (2018) Marc Vervloet Nature Reviews Nephrology
- Therapeutic Effects of FGF23 c-tail Fc in a Murine Preclinical Model of X-Linked Hypophosphatemia Via the Selective Modulation of Phosphate Reabsorption
- (2017) Kristen Johnson et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Identification of a novel functional JAK1 S646P mutation in acute lymphoblastic leukemia
- (2017) Qian Li et al. Oncotarget
- FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase
- (2017) Ingo Flamme et al. PLoS One
- Systemic Inflammation Affects Human Osteocyte-Specific Protein and Cytokine Expression
- (2016) Janak L. Pathak et al. CALCIFIED TISSUE INTERNATIONAL
- Serum Fibroblast Growth Factor 23 (FGF23) in Patients with Rheumatoid Arthritis
- (2016) Hiroe Sato et al. INTERNAL MEDICINE
- Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
- (2016) Saurav Singh et al. KIDNEY INTERNATIONAL
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Expression of Fgf23 in Activated Dendritic Cells and Macrophages in Response to Immunological Stimuli in Mice
- (2015) Yuki Masuda et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Inflammation but not obesity or insulin resistance is associated with increased plasma fibroblast growth factor 23 concentration in the elderly
- (2015) Michał Holecki et al. CLINICAL ENDOCRINOLOGY
- Functions of Fibroblast Growth Factor Receptors in cancer defined by novel translocations and mutations
- (2015) Leandro H. Gallo et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Janus kinase 3 regulates renal 25-hydroxyvitamin D 1α-hydroxylase expression, calcitriol formation, and phosphate metabolism
- (2015) Anja T. Umbach et al. KIDNEY INTERNATIONAL
- Regulation of FGF23 expression in IDG-SW3 osteocytes and human bone by pro-inflammatory stimuli
- (2015) Nobuaki Ito et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
- (2015) Chiara Degirolamo et al. NATURE REVIEWS DRUG DISCOVERY
- Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease
- (2014) Daniela Spichtig et al. KIDNEY INTERNATIONAL
- Coordinated regulation of TRPV5-mediated Ca2+ transport in primary distal convolution cultures
- (2014) Eline A. E. van der Hagen et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- An ENU Mutagenesis-Derived Mouse Model with a Dominant Jak1 Mutation Resembling Phenotypes of Systemic Autoimmune Disease
- (2013) Sibylle Sabrautzki et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibroblast Growth Factor 23 and Klotho: Physiology and Pathophysiology of an Endocrine Network of Mineral Metabolism
- (2013) Ming Chang Hu et al. Annual Review of Physiology
- Plasma Fibroblast Growth Factor 23 Concentration Is Increased and Predicts Mortality in Patients on the Liver-Transplant Waiting List
- (2013) Dominique Prié et al. PLoS One
- Fibroblast Growth Factor 23 and Inflammation in CKD
- (2012) J. Munoz Mendoza et al. Clinical Journal of the American Society of Nephrology
- Mechanism of FGF23 processing in fibrous dysplasia
- (2012) Nisan Bhattacharyya et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started